文献速递泌尿生殖腹部MRUS

多参数前列腺MRI中前列腺影像报告和数据系统第2版5类病灶经MRI-超声融合靶向穿刺证实为假阳性的研究

MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
PubMed 文献 · AJR Am J Roentgenol · 2018-02-28

研究纳入2015年1月至2016年7月325例接受前列腺多参数MRI及MRI-超声融合靶向穿刺的男性,前瞻性识别420个PI-RADS v2病灶,其中98个为PI-RADS 5类。98个PI-RADS 5类病灶中18%为良性,多因素分析显示良性病理与较低前列腺特异性抗原密度及尖部或底部位置相关;二次回顾中39%良性病灶被重新评分为良性前列腺增生结节。

要点

  • PI-RADS 5类病灶中18%(18/98)穿刺病理为良性。
  • 良性病理与较低PSA密度(OR 0.88)及尖部(OR 3.54)或底部(OR 7.11)位置相关。
  • 二次回顾中39%(7/18)良性病灶被评分为良性前列腺增生结节。

核心结论

  • 常规临床解读中识别的PI-RADS 5类病灶与临床显著前列腺癌高风险相关;良性病理结果与较低PSA密度及尖部或底部位置显著相关,且最常归因于良性前列腺增生结节;整合这些临床特征可能改善对mpMRI识别的高风险病灶的解读。

研究设计与样本

  • 研究类型为回顾性分析(对良性病理病灶进行二次回顾),2015年1月至2016年7月325例男性接受前列腺mpMRI后行MRI-超声融合靶向穿刺,前瞻性识别并评估420个PI-RADS v2病灶,其中89例患者共98个PI-RADS 5类病灶;参考标准为穿刺病理(临床显著前列腺癌定义为Gleason评分≥7)。

关键影像表现/征象

  • 98个PI-RADS 5类病灶中18%(18/98)为良性,10%(10/98)为Gleason 6病变,71%(70/98)为临床显著前列腺癌。
  • 18个良性病理病灶二次回顾中,39%(7/18)评分为良性前列腺增生结节,28%(5/18)为炎症改变,5%(1/18)为正常解剖结构,28%(5/18)与影像表现不一致。

诊断标准与关键数值

  • 临床显著前列腺癌定义为Gleason评分≥7。
  • 多因素分析中良性疾病的关联因素:较低前列腺特异性抗原密度(OR 0.88;p < 0.001)、尖部位置(OR 3.54;p = 0.001)、底部位置(OR 7.11;p = 0.012)。

临床应用与阅片要点

  • 作者认为整合较低PSA密度及尖部或底部位置等临床特征可能改善对mpMRI识别的高风险病灶的解读。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to determine imaging and clinical features associated with Prostate Imaging Reporting and Data System (PI-RADS) category 5 lesions identified prospectively at multiparametric MRI (mpMRI) that were found benign at MRI-ultrasound fusion targeted biopsy.

MATERIALS AND METHODS: Between January 2015 and July 2016, 325 men underwent prostate mpMRI followed by MRI-ultrasound fusion targeted biopsy of 420 lesions prospectively identified and assessed with PI-RADS version 2. The frequency of clinically significant prostate cancer (defined as Gleason score ≥ 7) among PI-RADS 5 lesions was determined. Lesions with benign pathologic results were retrospectively reassessed by three abdominal radiologists and categorized as concordant or discordant between mpMRI and biopsy results. Multivariate logistic regression was used to identify factors associated with benign disease. Bonferroni correction was used.

RESULTS: Of the 98 PI-RADS 5 lesions identified in 89 patients, 18% (18/98) were benign, 10% (10/98) were Gleason 6 disease, and 71% (70/98) were clinically significant prostate cancer. Factors associated with benign disease at multivariate analysis were lower prostate-specific antigen density (odds ratio [OR], 0.88; p < 0.001) and apex (OR, 3.54; p = 0.001) or base (OR, 7.11; p = 0.012) location. On secondary review of the 18 lesions with benign pathologic results, 39% (7/18) were scored as benign prostatic hyperplasia nodules, 28% (5/18) as inflammatory changes, 5% (1/18) as normal anatomic structures, and 28% (5/18) as discordant with imaging findings.

CONCLUSION: PI-RADS 5 lesions identified during routine clinical interpretation are associated with a high risk of clinically significant prostate cancer. A benign pathologic result was significantly correlated with lower prostate-specific antigen density and apex or base location and most commonly attributed to a benign prostatic hyperplasia nodule. Integration of these clinical features may improve the interpretation of high-risk lesions identified with mpMRI.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Sheridan AD, Nath SK, Aneja S, et al. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI. AJR Am J Roentgenol. 2018. PMID: 29489409. doi:10.2214/AJR.17.18680

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。